Crossmark

Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications

Crossref DOI link: https://doi.org/10.1136/bmjgh-2021-007211

Published Online: 2021-12-16

Published Print: 2021-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Pecenka, Clint

Usuf, Effua

Hossain, Ilias

Sambou, Sana

Vodicka, Elisabeth

Atherly, Deborah

Mackenzie, Grant
Funding

Funding for this research was provided by:

PATH (G17249)

Medical Research Council

Bill and Melinda Gates Foundation (OPP 1020327)

GAVI Alliance

Pfizer (WI222797)
License Information

License valid from 2021-12-16